{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:10Z","timestamp":1740184990884,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Zulassung komplementinhibitorischer Therapeutika zur Behandlung der geographischen Atrophie (GA) macht die verl\u00e4ssliche und reproduzierbare Messung von Krankheitsfortschreiten und Therapieerfolg unerl\u00e4sslich. Die optische Koh\u00e4renztomographie (OCT) ist aufgrund ihrer Verbreitung und Bildgebungscharakteristiken die Methode der Wahl. Anhand artificial intelligence (AI)-basierter OCT-Analyse konnte die therapeutische Wirksamkeit von Pegcetacoplan auf retinaler Pigmentepithel(RPE)- und Photorezeptor(PR)-Ebene nachgewiesen werden. Cloud-basierte L\u00f6sungen, die das GA-Monitoring erm\u00f6glichen, stehen bereits zur Verf\u00fcgung.<\/jats:p>","DOI":"10.1007\/s00347-024-02039-z","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:51:57Z","timestamp":1714567917000},"page":"476-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Komplementinhibitorentherapie bei geographischer Atrophie (GA): funktionelle und morphologische Wirksamkeit und relevante Biomarker in der klinischen Praxis","Complement inhibition treatment for geographic atrophy (GA): functional and morphological efficacy and relevant biomarkers in clinical practice"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-7311","authenticated-orcid":false,"given":"Ursula","family":"Schmidt-Erfurth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-0886","authenticated-orcid":false,"given":"Sophie","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"2039_CR1","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier\u00a0JS, Lad\u00a0EM, Holz\u00a0FG et\u00a0al (2023) Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase\u00a03\u00a0trials. Lancet 402:1434\u20131448","journal-title":"Lancet"},{"key":"2039_CR2","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani\u00a0AM, Patel\u00a0SS, Staurenghi\u00a0G et\u00a0al (2023) Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a\u00a0randomised, double-masked, phase\u00a03\u00a0trial. Lancet 402:1449\u20131458","journal-title":"Lancet"},{"key":"2039_CR3","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1167\/iovs.17-22339","volume":"58","author":"K Csaky","year":"2017","unstructured":"Csaky\u00a0K, Ferris\u00a0F 3rd, Chew\u00a0EY, Nair\u00a0P, Cheetham\u00a0JK, Duncan\u00a0JL (2017) Report from the NEI\/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases. Invest Ophthalmol Vis Sci 58:3456\u20133463","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2039_CR4","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1167\/iovs.05-1027","volume":"47","author":"JC Hwang","year":"2006","unstructured":"Hwang\u00a0JC, Chan\u00a0JW, Chang\u00a0S, Smith\u00a0RT (2006) Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2655\u20132661","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2039_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","volume":"125","author":"M Fleckenstein","year":"2018","unstructured":"Fleckenstein\u00a0M, Mitchell\u00a0P, Freund\u00a0KB et\u00a0al (2018) The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125:369\u2013390","journal-title":"Ophthalmology"},{"key":"2039_CR6","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1167\/iovs.08-1967","volume":"49","author":"M Fleckenstein","year":"2008","unstructured":"Fleckenstein\u00a0M, Charbel Issa\u00a0P, Helb\u00a0HM et\u00a0al (2008) High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 49:4137\u20134144","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2039_CR7","volume-title":"RetInSight secures the first MDR CE-certification for its AI-based GA monitor for the management of geographic atrophy","author":"H RetInSight-Gmb","year":"2023","unstructured":"RetInSight-Gmb\u00a0H (2023) RetInSight secures the first MDR CE-certification for its AI-based GA monitor for the management of geographic atrophy"},{"key":"2039_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ajo.2021.08.018","volume":"235","author":"CC Wykoff","year":"2022","unstructured":"Wykoff\u00a0CC, Hershberger\u00a0V, Eichenbaum\u00a0D et\u00a0al (2022) Inhibition of complement factor 3 in geographic atrophy with NGM621: phase\u00a01 dose-escalation study results. Am J Ophthalmol 235:131\u2013142","journal-title":"Am J Ophthalmol"},{"key":"2039_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","volume":"37","author":"DS Boyer","year":"2017","unstructured":"Boyer\u00a0DS, Schmidt-Erfurth\u00a0U, van Lookeren Campagne\u00a0M, Henry\u00a0EC, Brittain\u00a0C (2017) The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a\u00a0therapeutic target. Retina 37:819\u2013835","journal-title":"Retina"},{"key":"2039_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.ophtha.2011.01.043","volume":"118","author":"RG Sayegh","year":"2011","unstructured":"Sayegh\u00a0RG, Simader\u00a0C, Scheschy\u00a0U et\u00a0al (2011) A\u00a0systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology 118:1844\u20131851","journal-title":"Ophthalmology"},{"key":"2039_CR11","doi-asserted-by":"publisher","first-page":"557 e1","DOI":"10.1016\/j.ajo.2014.05.026","volume":"158","author":"C Simader","year":"2014","unstructured":"Simader\u00a0C, Sayegh\u00a0RG, Montuoro\u00a0A et\u00a0al (2014) A\u00a0longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy. Am J Ophthalmol 158:557 e1\u2013566 e1","journal-title":"Am J Ophthalmol"},{"key":"2039_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajo.2022.06.023","volume":"244","author":"J Mai","year":"2022","unstructured":"Mai\u00a0J, Riedl\u00a0S, Reiter\u00a0GS et\u00a0al (2022) Comparison of fundus autofluorescence versus optical coherence tomography-based evaluation of the therapeutic response to pegcetacoplan in geographic atrophy. Am J Ophthalmol 244:175\u2013182","journal-title":"Am J Ophthalmol"},{"key":"2039_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/IAE.0000000000001946","volume":"38","author":"KM Litts","year":"2018","unstructured":"Litts\u00a0KM, Zhang\u00a0Y, Freund\u00a0KB, Curcio\u00a0CA (2018) Optical coherence tomography and histology of age-related macular degeneration support mitochondria as reflectivity sources. Retina 38:445\u2013461","journal-title":"Retina"},{"key":"2039_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.07.004","volume":"67","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth\u00a0U, Sadeghipour\u00a0A, Gerendas\u00a0BS, Waldstein\u00a0SM, Bogunovic\u00a0H (2018) Artificial intelligence in retina. Prog Retin Eye Res 67:1\u201329","journal-title":"Prog Retin Eye Res"},{"key":"2039_CR15","first-page":"431","volume-title":"Projective skip-connections for segmentation along a\u00a0subset of dimensions in retinal OCT","author":"D Lachinov","year":"2021","unstructured":"Lachinov\u00a0D, Seeb\u00f6ck\u00a0P, Mai\u00a0J, Goldbach\u00a0F, Schmidt-Erfurth\u00a0U, Bogunovic\u00a0H (2021) Projective skip-connections for segmentation along a\u00a0subset of dimensions in retinal OCT. Springer International Publishing, Cham, S\u00a0431\u2013441"},{"key":"2039_CR16","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1038\/s41598-023-34139-2","volume":"13","author":"J Mai","year":"2023","unstructured":"Mai\u00a0J, Lachinov\u00a0D, Riedl\u00a0S et\u00a0al (2023) Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment. Sci Rep 13:7028","journal-title":"Sci Rep"},{"key":"2039_CR17","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1038\/s41598-020-62329-9","volume":"10","author":"JI Orlando","year":"2020","unstructured":"Orlando\u00a0JI, Gerendas\u00a0BS, Riedl\u00a0S et\u00a0al (2020) Automated quantification of photoreceptor alteration in macular disease using optical coherence tomography and deep learning. Sci Rep 10:5619","journal-title":"Sci Rep"},{"key":"2039_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/bjophthalmol-2014-305195","volume":"98","author":"RG Sayegh","year":"2014","unstructured":"Sayegh\u00a0RG, Kiss\u00a0CG, Simader\u00a0C et\u00a0al (2014) A\u00a0systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic atrophy. Br J Ophthalmol 98:1050\u20131055","journal-title":"Br J Ophthalmol"},{"key":"2039_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajo.2016.06.006","volume":"168","author":"A Takahashi","year":"2016","unstructured":"Takahashi\u00a0A, Ooto\u00a0S, Yamashiro\u00a0K et\u00a0al (2016) Photoreceptor damage and reduction of retinal sensitivity surrounding geographic atrophy in age-related macular degeneration. Am J Ophthalmol 168:260\u2013268","journal-title":"Am J Ophthalmol"},{"key":"2039_CR20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ajo.2011.11.002","volume":"153","author":"L Querques","year":"2012","unstructured":"Querques\u00a0L, Querques\u00a0G, Forte\u00a0R, Souied\u00a0EH (2012) Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration. Am J Ophthalmol 153:1110\u20131115","journal-title":"Am J Ophthalmol"},{"key":"2039_CR21","volume-title":"Stealth biotherapeutics announces positive end-of-phase\u00a02 meeting with FDA on the development of elamipretide in patients with dry age-related macular degeneration","author":"Stealth-Biotherapeutics","year":"2023","unstructured":"Stealth-Biotherapeutics (2023) Stealth biotherapeutics announces positive end-of-phase\u00a02 meeting with FDA on the development of elamipretide in patients with dry age-related macular degeneration"},{"key":"2039_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.oret.2022.05.030","volume":"6","author":"S Riedl","year":"2022","unstructured":"Riedl\u00a0S, Vogl\u00a0WD, Mai\u00a0J et\u00a0al (2022) The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence-based OCT analysis. Ophthalmol Retina 6:1009\u20131018","journal-title":"Ophthalmol Retina"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-02039-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T17:03:13Z","timestamp":1718643793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-02039-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-02039-z","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"type":"print","value":"2731-720X"},{"type":"electronic","value":"2731-7218"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U. Schmidt-Erfurth macht folgende Angaben: Grants or contracts from any entity: RetInSight, Heidelberg Engineering, Apellis Pharmaceuticals. Consulting fees: Heidelberg Engineering, Apellis Pharmaceuticals. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events and support for attending meetings and\/or travel: Apellis Pharmaceuticals. S.\u00a0Riedl gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}